Agenus to Release Third-Quarter 2026 Results on November 5
Agenus said it will release its third-quarter 2026 financial results before the market opens on November 5, 2026, and review recent development progress.
Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that the Company will release its third quarter 2026 financial results before the market opens on Thursday, November 5, 2026.The earnings release will review Agenus’ recent progress in advancing botensili…